These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 23053688

  • 1. A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis.
    Chen XX, Dai Q, Huang AB, Wu HX, Zhao DB, Li XF, Hu SX, Yang NP, Tao Y, Xu JH, Jiang LD, Bao CD.
    Clin Rheumatol; 2013 Jan; 32(1):99-108. PubMed ID: 23053688
    [Abstract] [Full Text] [Related]

  • 2. A randomized, controlled trial of efficacy and safety of Anbainuo, a bio-similar etanercept, for moderate to severe rheumatoid arthritis inadequately responding to methotrexate.
    Chen XX, Li ZG, Wu HX, Zhao DB, Li XF, Xu JH, Tao Y, Yang NP, Hu SX, Huang AB, Jiang LD, Wang GC, Zhang X, Bao CD.
    Clin Rheumatol; 2016 Sep; 35(9):2175-83. PubMed ID: 27184046
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate.
    Fan W, Zhao DB, Hu SX, Xu HJ, Zhang X, Zhang MJ, Chen ZW, Zhang FX, Zhu P, Li XF, Bi LQ, Zhou B, Bao CD.
    Rheumatol Int; 2014 Nov; 34(11):1519-27. PubMed ID: 24671501
    [Abstract] [Full Text] [Related]

  • 4. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
    Moreland LW, O'Dell JR, Paulus HE, Curtis JR, Bathon JM, St Clair EW, Bridges SL, Zhang J, McVie T, Howard G, van der Heijde D, Cofield SS, TEAR Investigators.
    Arthritis Rheum; 2012 Sep; 64(9):2824-35. PubMed ID: 22508468
    [Abstract] [Full Text] [Related]

  • 5. Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial.
    O'Dell JR, Curtis JR, Mikuls TR, Cofield SS, Bridges SL, Ranganath VK, Moreland LW, TEAR Trial Investigators.
    Arthritis Rheum; 2013 Aug; 65(8):1985-94. PubMed ID: 23686414
    [Abstract] [Full Text] [Related]

  • 6. A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.
    Hu D, Bao C, Chen S, Gu J, Li Z, Sun L, Han X, Ni L.
    Rheumatol Int; 2009 Jan; 29(3):297-303. PubMed ID: 18704426
    [Abstract] [Full Text] [Related]

  • 7. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.
    Lan JL, Chou SJ, Chen DY, Chen YH, Hsieh TY, Young M.
    J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
    Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martín Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M, TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators.
    Lancet; 2004 Feb 28; 363(9410):675-81. PubMed ID: 15001324
    [Abstract] [Full Text] [Related]

  • 9. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA, Guzman RM, Xavier RM, Simon JA, Mele L, Pedersen R, Ferdousi T, Koenig AS, Kotak S, Vlahos B.
    J Clin Rheumatol; 2014 Jan 28; 20(1):25-33. PubMed ID: 24356474
    [Abstract] [Full Text] [Related]

  • 10. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
    van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, Tornero-Molina J, Wajdula J, Pedersen R, Fatenejad S, TEMPO Study Investigators.
    Arthritis Rheum; 2006 Apr 28; 54(4):1063-74. PubMed ID: 16572441
    [Abstract] [Full Text] [Related]

  • 11. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.
    Kameda H, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Takeuchi T, Japan Biological Agent Study Integrated Consortium.
    Mod Rheumatol; 2010 Dec 28; 20(6):531-8. PubMed ID: 20574649
    [Abstract] [Full Text] [Related]

  • 12. Randomized comparison of etanercept with usual therapy in an Asian population with active rheumatoid arthritis: the APPEAL trial.
    Kim HY, Hsu PN, Barba M, Sulaiman W, Robertson D, Vlahos B, Khandker R, Nab H, Freundlich B, Koenig A.
    Int J Rheum Dis; 2012 Apr 28; 15(2):188-96. PubMed ID: 22462423
    [Abstract] [Full Text] [Related]

  • 13. Etanercept for the treatment of rheumatoid arthritis.
    Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.
    Cochrane Database Syst Rev; 2013 May 31; 2013(5):CD004525. PubMed ID: 23728649
    [Abstract] [Full Text] [Related]

  • 14. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.
    Arthritis Rheum; 2003 Jun 31; 48(6):1493-9. PubMed ID: 12794815
    [Abstract] [Full Text] [Related]

  • 15. Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study.
    Emery P, Breedveld F, van der Heijde D, Ferraccioli G, Dougados M, Robertson D, Pedersen R, Koenig AS, Freundlich B, Combination of Methotrexate and Etanercept in Early Rheumatoid Arthritis Trial Group.
    Arthritis Rheum; 2010 Mar 31; 62(3):674-82. PubMed ID: 20187135
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B.
    J Rheumatol; 2006 Feb 31; 33(2):234-43. PubMed ID: 16465653
    [Abstract] [Full Text] [Related]

  • 17. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.
    Emery P, Fleischmann RM, Moreland LW, Hsia EC, Strusberg I, Durez P, Nash P, Amante EJ, Churchill M, Park W, Pons-Estel BA, Doyle MK, Visvanathan S, Xu W, Rahman MU.
    Arthritis Rheum; 2009 Aug 31; 60(8):2272-83. PubMed ID: 19644849
    [Abstract] [Full Text] [Related]

  • 18. Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study.
    Smolen JS, Kay J, Matteson EL, Landewé R, Hsia EC, Xu S, Zhou Y, Doyle MK.
    Ann Rheum Dis; 2014 Oct 31; 73(10):1811-8. PubMed ID: 23897769
    [Abstract] [Full Text] [Related]

  • 19. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
    Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT.
    Arthritis Rheum; 2006 Jan 31; 54(1):26-37. PubMed ID: 16385520
    [Abstract] [Full Text] [Related]

  • 20. A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis.
    Takeuchi T, Miyasaka N, Zang C, Alvarez D, Fletcher T, Wajdula J, Yuasa H, Vlahos B.
    Mod Rheumatol; 2013 Jul 31; 23(4):623-33. PubMed ID: 23011358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.